Key result
STE shows a moderate ~0.57 correlation with CMR-FT for LV-GLS, stronger in cardiovascular disease.
Why the study?
The strength of cross-modal correlation between LV-GLS measured by STE and CMR-FT, and its consistency across clinical phenotypes, remained uncertain.
Does LV-GLS measured by STE correlate with CMR-FT in healthy and cardiovascular disease cohorts?
Meta-Analysis (n=624)
Does LV-GLS measured by STE correlate with CMR-FT in healthy and cardiovascular disease cohorts?
Answers are grounded in this paper and cite their sources.
STE and CMR-FT GLS show moderate cross-modal correlation that is stronger in cardiovascular disease than in health, but the modalities are not numerically interchangeable.
BACKGROUND Left Ventricular global longitudinal strain (LV-GLS) can be measured by speckle-tracking echocardiography (STE) and by cardiac magnetic resonance feature tracking (CMR-FT), but the strength of cross-modal correlation and its consistency across clinical phenotypes remain uncertain. METHODS We performed a systematic review and meta-analysis of studies reporting LV-GLS by both STE and CMR-FT in the same cohorts. Reported patient-level correlation coefficients (Pearson r) between modalities were pooled using Fisher's z-transformation and random-effects models, with prespecified subgroup analyses for healthy cohorts and cohorts with cardiovascular disease (CD). RESULTS Eleven studies met inclusion criteria; 18 cohorts (n = 624) reported patient-level correlations and were analyzed. Overall, STE GLS and CMR-FT GLS showed a moderate pooled correlation (sample-size-weighted r = 0.57; 95% CI 0.32 to 0.74) with substantial heterogeneity (I2 = 91.6%). In healthy cohorts (5 cohorts; n = 87) correlation was low and not statistically significant (r = 0.38; 95% CI -0.37 to 0.83). In CD cohorts (13 cohorts; n = 537), correlation was higher and statistically significant (r = 0.62; 95% CI 0.38 to 0.78). CONCLUSIONS STE and CMR-FT GLS show a moderate cross-modal correlation overall, which is attenuated in health and stronger in CD. These findings quantify association rather than individual-level agreement and do not support numerical interchangeability between modalities.
No takes yet. Share an insight, caveat, or question.
Pascalis et al. (2026) conducted a meta-analysis in Cardiovascular disease and healthy cohorts (n=624). Speckle-tracking echocardiography (STE) vs. Cardiac magnetic resonance feature tracking (CMR-FT) was evaluated on Patient-level correlation coefficients (Pearson r) between modalities (r 0.57, 95% CI 0.32 to 0.74). Speckle-tracking echocardiography and CMR feature tracking for LV-GLS showed a moderate pooled correlation overall, which was stronger in cardiovascular disease.
Synapse has enriched 10 related papers. Consider them for comparative context: